Boston Scientific Executive Q&A at TD Cowen Health Care Conference, March 3, 2026

Boston Scientific Schedules Executive Q&A at TD Cowen Conference

Boston Scientific is set to present at TD Cowen’s 46th Annual Health Care Conference on March 3, 2026, where Chairman and Chief Executive Officer Mike Mahoney and Senior Vice President and Global Chief Medical Officer Kenneth Stein will take part in a roughly 30‑minute question‑and‑answer session. The management discussion, scheduled for about 9:10 a.m. ET, is slated to focus on strategy, recent clinical and commercial progress and near‑term priorities, the company says. A live webcast and a replay, available about an hour after the session concludes, are accessible via the company’s investor relations site.

The appearance gives Boston Scientific a platform to update investors, analysts and the medical community on advances across its broad device portfolio, which addresses cardiovascular, respiratory, digestive, oncological, neurological and urological conditions. Company executives are expected to address how recent clinical outcomes and product launches are translating into commercial traction and how that momentum informs near‑term R&D and market priorities. The session also provides a forum for the host analyst to probe regulatory pathways, trial readouts and market access strategies for key programs.

The presentation follows an active period for the medical device maker as it continues to position itself around cost‑effective therapies and expanding clinical indications. By placing senior clinical and commercial leadership on stage together, Boston Scientific aims to link clinical evidence with commercialization plans and to signal continuity in medical and business strategy to customers and healthcare partners.

Quarterly performance context

Boston Scientific reports that net sales for the fourth quarter of 2025 total $5.286 billion, a 15.9% reported increase year‑over‑year, underscoring commercial momentum heading into the March presentation. The company frames the quarterly results as a backdrop for the conference update, linking topline growth to recent product performance and market expansion.

Access and contacts

The company directs interested parties to its investor relations site for the live webcast and replay (https://investors.bostonscientific.com) and to its corporate website and LinkedIn for additional materials. Media and investor contacts listed in the notice include Chanel Hastings, Media Relations, and Lauren Tengler, Investor Relations, for further information.